[
  {
    "ts": null,
    "headline": "Vaccine stocks tumble: Moderna, Novavax, Pfizer fall after top FDA official resigns over RFK Jr. anti-vax views",
    "summary": "The health agency’s top immunization official announced the move Monday in protest, citing Secretary Kennedy’s ‘misinformation and lies.’",
    "url": "https://finnhub.io/api/news?id=f695eabc616aa3e3e745905d68f8b22627ccc1fc60f4cb6627e98bb9d0fdb0cd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743445800,
      "headline": "Vaccine stocks tumble: Moderna, Novavax, Pfizer fall after top FDA official resigns over RFK Jr. anti-vax views",
      "id": 133658294,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The health agency’s top immunization official announced the move Monday in protest, citing Secretary Kennedy’s ‘misinformation and lies.’",
      "url": "https://finnhub.io/api/news?id=f695eabc616aa3e3e745905d68f8b22627ccc1fc60f4cb6627e98bb9d0fdb0cd"
    }
  },
  {
    "ts": null,
    "headline": "FDA Shake-Up Rocks Moderna Stock As Regulatory Risks Mount (Downgrade)",
    "summary": "Moderna stock dips 10% amid FDA resignation, signaling regulatory risks. Strong cash reserves can't offset competitive and mRNA challenges. Learn more on MRNA stock here.",
    "url": "https://finnhub.io/api/news?id=1abcd43be9f4a0eeccc15fb378281e4bec4d2933718fde9cc0cc077336b4abdb",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743441314,
      "headline": "FDA Shake-Up Rocks Moderna Stock As Regulatory Risks Mount (Downgrade)",
      "id": 133629673,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1316007813/image_1316007813.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Moderna stock dips 10% amid FDA resignation, signaling regulatory risks. Strong cash reserves can't offset competitive and mRNA challenges. Learn more on MRNA stock here.",
      "url": "https://finnhub.io/api/news?id=1abcd43be9f4a0eeccc15fb378281e4bec4d2933718fde9cc0cc077336b4abdb"
    }
  },
  {
    "ts": null,
    "headline": "Vaxcyte: Plunge On FDA Top Regulator Resigning Generates Buying Opportunity",
    "summary": "Vaxcyte: Plunge On FDA Top Regulator Resigning Generates Buying Opportunity",
    "url": "https://finnhub.io/api/news?id=24979e2617e266c7a79b3e966e43df9a0f685fc1bc5713f8a051c5e875deef11",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743435548,
      "headline": "Vaxcyte: Plunge On FDA Top Regulator Resigning Generates Buying Opportunity",
      "id": 133629198,
      "image": "",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=24979e2617e266c7a79b3e966e43df9a0f685fc1bc5713f8a051c5e875deef11"
    }
  },
  {
    "ts": null,
    "headline": "Moderna, Novavax Stocks Fall After Top FDA Vaccine Official Forced Out",
    "summary": "Shares in Moderna and Novavax fell Monday, following a Wall Street Journal report that the Food and Drug Administration’s top vaccine official has been pushed out. Shares in some larger drugmakers, such as GSK, also retreated.",
    "url": "https://finnhub.io/api/news?id=1b61a4ef03c586683607e065b5b8eb0bfb06fb7f71b07b8df86d8291e2d13e78",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743427903,
      "headline": "Moderna, Novavax Stocks Fall After Top FDA Vaccine Official Forced Out",
      "id": 133627873,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Shares in Moderna and Novavax fell Monday, following a Wall Street Journal report that the Food and Drug Administration’s top vaccine official has been pushed out. Shares in some larger drugmakers, such as GSK, also retreated.",
      "url": "https://finnhub.io/api/news?id=1b61a4ef03c586683607e065b5b8eb0bfb06fb7f71b07b8df86d8291e2d13e78"
    }
  },
  {
    "ts": null,
    "headline": "Is Trending Stock Pfizer Inc. (PFE) a Buy Now?",
    "summary": "Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
    "url": "https://finnhub.io/api/news?id=f4a13b2b7e05076bf584b68ba8489ae317050c79d80cd3ec907e46f95d410b75",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743426013,
      "headline": "Is Trending Stock Pfizer Inc. (PFE) a Buy Now?",
      "id": 133627874,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
      "url": "https://finnhub.io/api/news?id=f4a13b2b7e05076bf584b68ba8489ae317050c79d80cd3ec907e46f95d410b75"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Stock Sinks After Top FDA Official Resigns; Sarepta Gets Hit, Too.",
    "summary": "Moderna Stock Sinks After Top FDA Official Resigns; Sarepta Gets Hit, Too.",
    "url": "https://finnhub.io/api/news?id=dac1b16fbac4416eca8fbbbacaede5492fc24798b879c1772ec175a095dfb0f1",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743418020,
      "headline": "Moderna Stock Sinks After Top FDA Official Resigns; Sarepta Gets Hit, Too.",
      "id": 133637977,
      "image": "",
      "related": "PFE",
      "source": "MarketWatch",
      "summary": "Moderna Stock Sinks After Top FDA Official Resigns; Sarepta Gets Hit, Too.",
      "url": "https://finnhub.io/api/news?id=dac1b16fbac4416eca8fbbbacaede5492fc24798b879c1772ec175a095dfb0f1"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer: Looks Better Than Most, But I Can't Eat Relative Returns",
    "summary": "Pfizer's stock is cheap but faces operational challenges. Analyze its valuation and performance to make informed investment decisions. Read why PFE stock is a Hold.",
    "url": "https://finnhub.io/api/news?id=065088241777b4d698a1d421c559bb8535f2a8c517f42c1694bc134fe30bfae0",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743408000,
      "headline": "Pfizer: Looks Better Than Most, But I Can't Eat Relative Returns",
      "id": 133625375,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1292440985/image_1292440985.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Pfizer's stock is cheap but faces operational challenges. Analyze its valuation and performance to make informed investment decisions. Read why PFE stock is a Hold.",
      "url": "https://finnhub.io/api/news?id=065088241777b4d698a1d421c559bb8535f2a8c517f42c1694bc134fe30bfae0"
    }
  }
]